Email page to a friendBookmark this page
tufts.edu
    Home  
 
 
  Number of Therapeutic Peptides in Clinical Study Has Nearly Doubled Since the 1990s  
   
   

The Tufts Center for the Study of Drug Development recently celebrated its 30th anniversary. We want to thank our many colleagues and friends who over the years have offered — and continue to provide — advice, guidance, and support.

Louis Lasagna Library of Drug Development Science and Policy
We take this opportunity to acknowledge the founder of the Tufts Center, Dr. Louis Lasagna, and announce the renaming of the Tufts Center’s library in his honor.

   
Welcome to the Tufts Center. I invite you to learn more about us.

Read More >>
 
   Your Guide to Drug Development...  
 
Tufts CSDD Impact Reports
A bi-monthly, authoritative analysis of critical drug development issues. Each report features breakthrough research and analyses on the following topics:

* Clinical outsourcing is associated with faster development times
* The U.S. Pediatric Studies Initiative and its impact on new labeling for drugs
* Drug safety withdrawals in the PDUFA era
* Important changes in the investigative site landscape
* Growing FDA demand for postmarketing studies as a condition for approval
* The impact of therapeutic class on drug development time and cost

Click here for more information

Home - About Us - CSDD Institute - Information Services - Research - Publications - News & Events - Links - Contact Us - Site Map
Copyright © 2009 Tufts Center for the Study of Drug Development. All Rights Reserved.
Site Last Updated: June 19, 2009
Download Adobe Acrobat   Bookmark Page   Send this page